Acorda files patent infringement suit over MS drug Ampyra

By Leif Skodnick

No Comment

The Ardsley company alleges that Mylan Inc.’s application to get a generic form of the drug approved constitutes infringement of Acorda’s patents.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author

Leif Skodnick
Leif Skodnick is a former reporter for Westfair Communications. He is a graduate of Columbia Journalism School, Mississippi College School of Law, and St. Lawrence University.

Related Articles